Financial Ratios | Aarti Drugs Ltd. | R Wadiwala Securities Pvt Ltd
NIFTY16818.10  -40.50 (-0.24%)
SENSEX56409.96  -188.32 (-0.33%)
  • top gainers
  • top losers
  • top volume
  • top value
  • indian indices
  • global indices

AARTI DRUGS LTD.

NSE : AARTIDRUGSBSE : 524348ISIN CODE : INE767A01016Industry : Pharmaceuticals & DrugsHouse : Aarti
BSE464.4517.6 (+3.94 %)
PREV CLOSE (Rs.) 446.85
OPEN PRICE (Rs.) 448.05
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 13591
TODAY'S LOW / HIGH (Rs.)448.05 466.45
52 WK LOW / HIGH (Rs.)378.4 645
NSE463.9015.25 (+3.4 %)
PREV CLOSE( Rs. ) 448.65
OPEN PRICE (Rs.) 449.40
BID PRICE (QTY) 463.90 (3015)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 143733
TODAY'S LOW / HIGH(Rs.) 448.95 467.00
52 WK LOW / HIGH (Rs.)378 645.6

Financial Ratios

Select year
ParticularsMar2022Mar2021Mar2020Mar2019Mar2018
Operational & Financial Ratios
   Earnings Per Share (Rs)22.1430.0960.6938.0634.90
   CEPS(Rs)27.5435.4420.4014.0312.97
   DPS(Rs)1.002.502.001.001.00
   Book NAV/Share(Rs)111.9298.01280.04230.45193.12
   Tax Rate(%)24.0624.0123.6931.5033.89
Margin Ratios
   Core EBITDA Margin(%)13.3620.4414.7013.5115.99
   EBIT Margin(%)11.8118.3412.3311.1812.90
   Pre Tax Margin(%)10.8517.1310.268.399.86
   PAT Margin (%)8.2413.017.835.756.52
   Cash Profit Margin (%)10.2515.3310.538.489.69
Performance Ratios
   ROA(%)10.3216.789.336.316.38
   ROE(%)21.0335.8123.6517.9719.24
   ROCE(%)20.7534.5221.3917.0117.31
   Asset Turnover(x)1.251.291.191.100.98
   Sales/Fixed Asset(x)2.192.021.811.661.44
   Working Capital/Sales(x)5.494.676.438.0710.96
Efficiency Ratios
   Fixed Capital/Sales(x)0.460.490.550.600.70
   Receivable days95.7188.4195.7197.4597.10
   Inventory Days69.0062.7157.8061.3670.52
   Payable days90.2895.2792.6390.28112.73
Valuation Parameters
   PER(x)19.3723.092.0816.8314.52
   PCE(x)15.5819.616.2011.419.76
   Price/Book(x)3.837.091.812.782.62
   Yield(%)0.230.360.400.160.20
   EV/Net Sales(x)1.803.160.861.291.40
   EV/Core EBITDA(x)13.0515.315.819.438.56
   EV/EBIT(x)15.2717.236.9611.5310.66
   EV/CE(x)2.033.860.981.381.25
   M Cap / Sales1.603.010.650.970.96
Growth Ratio
   Net Sales Growth(%)15.4919.3115.7125.524.05
   Core EBITDA Growth(%)-22.7066.6325.165.134.33
   EBIT Growth(%)-25.6577.4727.617.174.38
   PAT Growth(%)-26.8998.3057.549.050.62
   EPS Growth(%)-26.41-50.4259.459.051.79
Financial Stability Ratios
   Total Debt/Equity(x)0.520.380.580.931.20
   Current Ratio(x)1.481.781.451.331.19
   Quick Ratio(x)0.921.080.930.910.74
   Interest Cover(x)12.2915.075.954.014.25
   Total Debt/Mcap(x)0.140.050.320.340.46